Myelofibrosis: Beyond Ruxolitinib
Other JAK inhibitors, combinations, and novel therapies offer more hope for patients
United States James Rossetti Mike Bassett Naveen Pemmaraju Hillman Cancer Center University Of Texas Md Anderson Cancer Center
Source: medpagetoday.com